MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 01-13-2026
Bio-Path Holdings EV/EBITDA Ratio 2011-2026 | BPTH
Annual EV/EBITDA Ratio Bio-Path Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.24 | -0.17 | 0.407 | -0.0267 | -2.01 | -9.29 | -22.1 | -43 | -99 | -8.19 | -5.81 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.407 | -99 | -17.2 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
ADMA Biologics
ADMA
|
-4.17 | $ 16.49 | -0.3 % | $ 3.93 B | USA |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
9.24 | $ 3.59 | -1.1 % | $ 1.07 B |  Canada |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
-6.39 | $ 20.5 | 3.22 % | $ 2.59 B | USA |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.81 | -1.57 % | $ 4.42 M | China |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
109 | $ 75.14 | -1.82 % | $ 1.45 B | USA |
 |
Applied Therapeutics
APLT
|
-0.476 | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.57 | -3.68 % | $ 401 M | Britain |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
-1.76 | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
-8.03 | $ 163.09 | -0.61 % | $ 8.11 B | USA |
 |
Champions Oncology
CSBR
|
77 | $ 6.0 | - | $ 82 M | USA |
 |
BridgeBio Pharma
BBIO
|
-4.37 | $ 65.5 | -1.57 % | $ 12.5 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | USA |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
Bellerophon Therapeutics
BLPH
|
0.0235 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
-53.5 | $ 2.84 | 1.07 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
671 | $ 60.3 | -0.22 % | $ 11.6 B | USA |
 |
Cabaletta Bio
CABA
|
0.778 | $ 3.37 | -1.75 % | $ 3.94 M | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-8.96 | $ 3.04 | -5.0 % | $ 1.09 M | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-2.36 | $ 0.59 | - | $ 549 K | Israel |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | Israel |
 |
Capricor Therapeutics
CAPR
|
-2.14 | $ 25.56 | 0.22 % | $ 684 M | USA |